Halozyme Therapeutics, Inc. Cash Flow Statement

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Dec2009	Dec2010	Dec2011	Dec2012	Dec2013	Dec2014	Dec2015	Dec2016	Dec2017	Dec2018	Dec2019	Dec2020	Dec2021	Dec2022	Dec2023	Dec2024
Operating Activities
Net Income	-0.06B	-0.05B	-0.02B	-0.05B	-0.08B	-0.07B	-0.03B	-0.10B	0.06B	-0.08B	-0.07B	0.13B	0.40B	0.20B	0.28B	0.44B
Depreciation and Depletion	327.00B
Share-based Compensation	0.00B	0.00B	0.01B	0.01B	0.01B	0.02B	0.02B	0.03B	0.03B	0.04B	0.03B	0.02B	0.02B	0.02B	0.04B	0.04B
Deferred Taxes													0.16B	-0.04B	-0.03B	-0.00B
Gains from Investment Securities	-0.00B	-0.00B	0.00B	0.00B	0.00B	-0.00B	0.00B	-0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.03B	0.03B	0.08B
Asset Writedowns and Impairment											0.00B	0.00B
Cash from Operations	-0.04B	-0.05B	-0.03B	-0.06B	-0.05B	-0.05B	-0.04B	-0.05B	0.13B	-0.05B	-0.09B	0.06B	0.30B	0.24B	0.39B	0.48B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles					-0.00B	-0.00B		-0.01B	0.00B	0.00B	0.00B	0.01B	0.00B	0.04B	0.07B	0.07B
Amortization of Deferred Charges				0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B
Depreciation & Amortization (CF)	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.01B	0.01B
Change in Working Capital
Change in Receivables	-0.00B	-0.00B	-0.00B	0.01B	-0.01B	0.00B	0.02B	-0.02B	0.01B	-0.01B	0.03B	0.04B	-0.01B	0.08B	0.00B	0.07B
Change in Inventory	0.00B	-0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	-0.01B	0.02B	0.01B	0.03B	-0.01B	0.02B	0.03B	0.07B
Change in Accured Expenses	-0.00B	0.00B	0.00B	-0.00B	0.01B	-0.00B	0.01B	-0.00B	0.02B	0.01B	0.00B	-0.04B	0.00B	0.02B	-0.01B	0.05B
Other Working Capital Changes	0.01B	-0.00B	-0.02B	0.00B	0.01B	0.01B	0.02B	-0.01B	0.02B	0.01B	0.02B	0.00B	0.01B	0.01B	-0.00B	-0.01B
Investing Activities
Capital Expenditures	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.00B	0.01B	0.02B	0.01B
Sales of Property, Plant and Equipment												0.00B		0.03B
Acquisitions														1.00B
Change in Acquisitions & Divestments					0.00B	0.06B	0.08B	0.08B	0.24B	0.32B	0.39B	0.31B	0.25B	0.75B	0.21B	0.40B
Cash from Investing Activities	-0.00B	-0.00B	-0.00B	-0.00B	-0.05B	-0.03B	0.01B	-0.08B	-0.16B	0.00B	-0.01B	0.08B	-0.41B	-0.49B	-0.10B	-0.26B
Financing Activities
Other financing activities	789.00B										0.00B		0.00B	0.01B
Cash from Financing Activities	0.05B	0.06B	0.00B	0.11B	0.03B	0.11B	0.01B	0.15B	0.13B	-0.06B	0.15B	-0.11B	0.08B	0.36B	-0.41B	-0.22B
Additional items
Change in Cash	0.00B	0.02B	-0.03B	0.05B	-0.07B	0.03B	-0.02B	0.02B	0.10B	-0.11B	0.06B	0.03B	-0.03B	0.12B	-0.12B	-0.00B
Beginning Cash Balance	0.06B	0.07B	0.08B	0.05B	0.10B	0.03B	0.06B	0.04B	0.07B	0.17B	0.06B	0.12B	0.15B	0.12B	0.23B	0.12B
Free Cash Flow	-0.04B	-0.05B	-0.04B	-0.07B	-0.05B	-0.05B	-0.04B	-0.05B	0.13B	-0.05B	-0.09B	0.05B	0.30B	0.23B	0.37B	0.47B
Net Cash Flow	0.00B	0.02B	-0.03B	0.05B	-0.07B	0.03B	-0.02B	0.02B	0.10B	-0.11B	0.06B	0.03B	-0.03B	0.12B	-0.12B	-0.00B

Research Tools

Halozyme Therapeutics, Inc. Cash Flow Statement

Create an account

Sign In

Reset Password

Get Pro for 60% off